- AMA-M2 Antibody (1)
- AMA-M2 Antibody
- GP210 Antibody (1)
- GP210 Antibody
- LC-1 Antibody (1)
- LC-1 Antibody
- LKM-1 Antibody (1)
- LKM-1 Antibody
- M2-3E (BPO) Antibody (1)
- M2-3E (BPO) Antibody
- PML Antibody (1)
- PML Antibody
- Ro-52 Antibody (1)
- Ro-52 Antibody
- SLA/LP Antibody (1)
- SLA/LP Antibody
- SP100 Antibody (1)
- SP100 Antibody
The “Autoimmune Liver Diseases Profile IgG” offered by Redcliffelab is a comprehensive panel designed to test for specific antibodies associated with autoimmune liver diseases. The tests included in this panel aim to identify specific antibodies that are often present in individuals with autoimmune liver diseases. Here’s a breakdown of the tests included in this panel:
Significance of the Package: Autoimmune liver diseases are conditions in which the immune system mistakenly targets and damages the liver. These diseases can lead to inflammation, scarring, and impaired liver function. Detecting specific antibodies associated with these diseases can help in diagnosing and monitoring autoimmune liver conditions such as primary biliary cholangitis (PBC), autoimmune hepatitis (AIH), and others.
The presence of these antibodies can provide valuable information for healthcare providers to accurately diagnose and manage autoimmune liver diseases. These tests can help differentiate between various autoimmune liver conditions and guide appropriate treatment strategies.
If you have symptoms of autoimmune liver diseases or have been diagnosed with a liver condition, this panel can provide insights into the presence of specific antibodies associated with these diseases. It’s important to consult with a healthcare provider for proper interpretation of the test results and appropriate medical guidance.